SRP Diabetes support for innovation
One goal for SRP Diabetes is to translate knowledge and findings into clinical practise in order to improve the situation for patients. To capture innovations and develop those into products or medications is one way of doing that.
In order to support this process SRP Diabetes is collaborating with Karolinska Institutet Innovations AB (KIAB). SRP Diabetes has from KIAB hired Patrik Blomquist who works as a dedicated Innovation Officer for SRP Diabetes and it’s research community.
KI Innovations also has financial support from VINNOVA (“Verifering för Tillväxt” in Swedish) that can be used for supporting commercial verification of research findings from KI. There are also other sources or soft money available for verify and develop the commercial potential of academic research. Since KI Innovations is collaborating with several strategic research programs (SFOs) processes developed in other areas will also be applied to SRP Diabetes.
SRP Diabetes also takes the advantage of Innovation Office at KI when it comes to interaction with industrial partners. All innovation support in SRP Diabetes is free of charge for the individual researcher.
SRP Diabetes Innovation Officer
SRP Diabetes offers different expertise on innovation to support its researchers in order to develop research findings into commercial products for the benefit of patients with diabetes.
Patrik Blomquist (employed at KIAB, firstname.lastname@example.org) is the Innovation Manager for SRP Diabetes. Patrik has a PhD in Molecular Biology from KI 1997 (supervisor Örjan Wrange), post-doc at Pharmacia, Project Manager at Target Discovery / Target Validation at Biovitrum for five years, Project Manager at KI (current Innovation Office) and has been a Project Manager at KI Innovations since May 2008. He lives on Lidingö with his family and in his free time he loves to perform long-distance running, hiking, skiing, skating, and triathlon.
Patrik’s task is together with SRP Diabetes researchers to:
- Identify commercial potential of research within the programme.
- Educate and inform about commercialization and patents.
- Aid in the contact with pharmaceutical and biotech companies.
- Represent SRP Diabetes in the new national innovation support structure SIO Chronic Diseases (see separate webpage).
- Advice about application for money that can be used for commercialization.
KI Innovations has soft money from Vinnova that can be used for supporting commercial verification of research findings from KI. There are also other sources “soft money” available for verify and develop the commercial potential of academic research. Since KI Innovations is collaborating with several strategic research programs (SFOs) Patrik can take advantage of what is done in them. Patrik also have access to the knowledge and competences within KI Innovations and the whole innovation system at KI.